Biotech

All Articles

Sanofi pays for $110M upfront for late-stage radioligand therapy

.Sanofi has actually brought in a late access to the radioligand party, paying out one hundred thous...

F 2G brings up $100M for second attempt to acquire new antifungal to market

.After F2G's initial effort to obtain a new training class of antifungal to market was derailed by t...

Moderna targets $1.1 B in R&ampD investing cuts, falls 5 plans in the middle of productivity stress

.Moderna has actually vowed to reduce R&ampD investing through $1.1 billion by 2027. The choice to s...

Sanofi's $80M bank on Pivot dystrophy medication finishes in stage 3 go under

.Merely four months after Sanofi wager $80 million in ahead of time cash money on Key Therapies' los...

Oncternal assets sinks 60% amid cutbacks, test firings

.Cancer company Oncternal Rehabs is folding all its clinical tests as well as laying off personnel, ...

Roche is carrying out hopes that its injectable excessive weight prospect could eventually display 25% weight loss in late-stage test

.Roche is storing out hopes that its injectable weight problems possibility could inevitably illustr...

Novo Nordisk barrages 'exceptional' weight-loss result for dual-acting oral medication in early test

.Novo Nordisk has actually lifted the cover on a period 1 test of its oral amylin and also GLP-1 rec...

AbbVie takes legal action against BeiGene over blood cancer drug secret method

.Simply a couple of short weeks after succeeding an FDA Fast lane tag for its own investigational BT...

Lilly supplies one-two punch along with 2nd tranche of beneficial records on once a week insulin applicant

.Quickly after a good information decrease for Eli Lilly's efsitora alfa, the Indianapolis-based pro...

BridgeBio cuts genetics therapy spending plan as clinical information let down

.BridgeBio Pharma is actually slashing its gene treatment budget plan and pulling back from the moda...